---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024769"
form_type: "8-K"
ticker: null
cik: "0001614067"
company_name: "Aridis Pharmaceuticals, Inc."
filed_at: "2023-07-18T23:59:59+00:00"
generated_at: "2026-06-13T07:04:10.581203+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Aridis receives Nasdaq delisting notice; shares to trade on OTC Pink Sheets from July 19

## Summary
- Nasdaq notified Aridis on July 17, 2023 that its common stock will be delisted from the Nasdaq Capital Market.
- Delisting becomes effective at the opening of trading on July 19, 2023.
- Company expects shares to trade on OTC Pink Sheets; will seek market makers to provide liquidity.
- No assurance that an active trading market for shares will develop post-delisting.

## SEC filing metadata
- accession: 0001493152-23-024769
- form_type: 8-K
- cik: 0001614067
- company_name: Aridis Pharmaceuticals, Inc.
- filed_at: 2023-07-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1614067/000149315223024769/0001493152-23-024769-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1614067/000149315223024769/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024769
- JSON: https://secwatch.observer/filing/0001493152-23-024769.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024769.txt

## Key facts
- Listing & Compliance Notices
  Aridis Pharmaceuticals, Inc. received a nasdaq delisting notice notice regarding other.
  - Exchange: nasdaq
  - Notice: delisting notice
  source text: July 17, 2023, Aridis Pharmaceuticals, Inc. (the “Company”) received written notice (the “ Notice ”) from the Nasdaq Stock Market, LLC (“ Nasdaq ”) that it would delist the Company’s shares of common stock from the Nasdaq Capital Market upon the opening of trading on July 19, 2023. The Company’s common stock will be traded on the OTC Pink Sheets and the Company will seek to establish relationships with market makers to provide additional trading opportunities in the Company’s stock. However, there can be no assurance that a market for the Company’s shares will develop. - 2 - SIGNATURES Pursuan
  evidence_url: https://www.sec.gov/Archives/edgar/data/1614067/000149315223024769/0001493152-23-024769-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.